The most notable companies in this group are lululemon athletica (NASDAQ:LULU), EQT Corp (NYSE:EQT), Sarepta Therapeutics (NASDAQ:SRPT).
The investment seeks capital appreciation.
The fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of mid cap companies. It normally allocates its assets among multiple investment strategies employed by the fund's investment adviser and affiliated and unaffiliated sub-advisers that invest primarily in equity securities issued by mid cap companies. The fund may invest up to 15% of its net assets in the equity securities of foreign issuers.
The average market capitalization across the BNY Mellon Mid Cap Multi-Strategy Inv MF is 34.79B. The market cap for tickers in the group ranges from 7.73B to 56.08B. ROP holds the highest valuation in this group at 56.08B. The lowest valued company is SRPT at 7.73B.
The average weekly volume growth across all stocks in the BNY Mellon Mid Cap Multi-Strategy Inv MF was 258%. For the same stocks of the MF, the average monthly volume growth was 12% and the average quarterly volume growth was 12%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 70
P/E Growth Rating: 62
Price Growth Rating: 37
SMR Rating: 56
Profit Risk Rating: 47
Seasonality Score: 3 (-100 ... +100)